XML 16 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Consolidated Statements of (Loss) Income - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Dec. 31, 2018
Dec. 31, 2017
Dec. 31, 2016
Revenues:      
Total revenues $ 103,269 $ 173,245 $ 150,246
Operating expenses:      
Cost of products 17,516 16,301 13,248
Research and development expenses 39,329 33,418 34,611
Selling, general and administrative expenses 100,359 58,860 44,179
Intangible asset amortization 6,619 3,659 13,888
(Gain) loss - changes in fair value of related party contingent consideration (22,731) (31,040) 49,285
Impairment of intangible asset 66,087 0 0
Restructuring costs 1,016 2,542 0
Total operating expenses 208,195 83,740 155,211
Operating (loss) income (104,926) 89,505 (4,965)
Investment and other income, net 452 2,136 2,758
Interest expense (10,622) (1,052) (963)
Other income (expense) - changes in fair value of related party payable 1,899 2,071 (6,548)
(Loss) income before income taxes (113,197) 92,660 (9,718)
Income tax (benefit) provision (17,893) 24,389 31,558
Net (loss) income $ (95,304) $ 68,271 $ (41,276)
Earnings (loss) per share      
Net income (loss) per share - basic (in usd per share) $ (2.55) $ 1.69 $ (1.00)
Net income (loss) per share - diluted (in usd per share) $ (2.55) $ 1.63 $ (1.00)
Weighted average number of shares outstanding      
Weighted average number of shares outstanding - basic (in shares) 37,325 40,465 41,248
Weighted average number of shares outstanding - diluted (in shares) 37,325 41,765 41,248
Product sales      
Revenues:      
Total revenues $ 101,423 $ 172,841 $ 147,222
License revenue      
Revenues:      
Total revenues $ 1,846 $ 404 $ 3,024